Context Therapeutics Inc. (CNTX) Statistics & Valuation Metrics - Stocknear

Context Therapeutics Inc.

NASDAQ: CNTX · Real-Time Price · USD
0.83
0.01 (1.17%)
At close: Sep 08, 2025, 3:18 PM

Context Therapeutics Statistics

Share Statistics

Context Therapeutics has 89.7M shares outstanding. The number of shares has increased by 19.61% in one year.

89.7M
19.61%
0%
75.02%
58.82M
234
0.11%

Short Selling Information

The latest short interest is 1.21M, so 1.35% of the outstanding shares have been sold short.

1.21M
1.35%
1.64%
9.96

Valuation Ratios

The PE ratio is -2.3 and the forward PE ratio is -2.12. Context Therapeutics's PEG ratio is 0.03.

-2.3
-2.12
0
36.8
0.64
-2.09
0.03
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Context Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 35.62, with a Debt / Equity ratio of 0.

35.62
35.62
0
-0.01
-0.01
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-2.23M
12
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -64.66% in the last 52 weeks. The beta is 1.91, so Context Therapeutics's price volatility has been higher than the market average.

1.91
-64.66%
0.77
0.88
51.84
220,075

Income Statement

n/a
n/a
-29.92M
-26.73M
-26.67M
-26.73M
-0.46
Full Income Statement

Balance Sheet

The company has 94.43M in cash and 219.38K in debt, giving a net cash position of 94.21M.

94.43M
219.38K
94.21M
-94.78M
87.15M
82.19M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -14.56M and capital expenditures -14.76M, giving a free cash flow of -29.31M.

-14.56M
-14.76M
-29.31M
-0.5
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

CNTX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for CNTX is $4, which is 387.8% higher than the current price. The consensus rating is "Buy".

$4
387.8%
Buy
5
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

7.91
2